Genome Med. 2025 May 26;17(1):61. doi: 10.1186/s13073-025-01491-z.
ABSTRACT
Many people with rare diseases cannot access personalized therapies because they do not have a confirmed genetic diagnosis. Promising technologies including proteomics are underutilized in routine diagnostic practice. It is time to incorporate proteomics into the diagnostic workflow to shorten time to diagnosis and expand treatment options for rare disease.
PMID:40420250 | DOI:10.1186/s13073-025-01491-z